Stock BIO BIOTON S.A.
Add to a list
To use this feature you must be a member
Log inSign up

News BIOTON S.A.

Equities

BIO

PLBIOTN00029

Delayed Warsaw S.E.
Other stock markets
 05:21:58 2024-05-02 am EDT 		5-day change 1st Jan Change
3.535 PLN +0.14% Intraday chart for BIOTON S.A. +1.00% -0.98%
Mar. 28 BIOTON S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 BIOTON S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BIOTON S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
BIOTON S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
BIOTON S.A. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
BIOTON S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
BIOTON S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
BIOTON S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
BIOTON S.A. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
BIOTON S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
BIOTON S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Bioton S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Brighter : Compatibility with New Insulins Opens Up New Market Opportunities for Brighter's Actiste
AQ
Bioton S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Yifan Pharmaceutical Co., Ltd. completed the acquisition of 19.79% stake in BIOTON S.A. from Ningbo Free Trade Zone Dongren Investment Co., Ltd.
CI
Yifan Pharmaceutical Co., Ltd. completed the acquisition of 11.86% stake in BIOTON S.A. from Kelipond Investment Limited.
CI
Yifan Pharmaceutical Co., Ltd. signed an agreement to acquire 11.86% stake in BIOTON S.A. from Kelipond Investment Limited for approximately CNY 270 million.
CI
Yifan Pharmaceutical Co., Ltd. agreed to acquire 19.79% stake in BIOTON S.A. from Ningbo Free Trade Zone Dongren Investment Co., Ltd. for approximately CNY 450 million.
CI
YiFan International Pharmaceutical Co., Limited completed the acquisition of SciGen Ltd from BIOTON S.A. and others.
CI
YiFan International Pharmaceutical Co., Limited made a pre conditional offer to acquire SciGen Ltd from BIOTON S.A. and others for $28 million.
CI
BIOTON Seeks Investor For SciGen Stake
CI
Medwise Pharmaceuticals Limited completed the acquisition of Tricel S.A. from BIOTON S.A..
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIO Stock
  4. News BIOTON S.A.